Trials / Sponsors / Nagla Abdel Karim
Nagla Abdel Karim
Academic / Other · 1 registered clinical trial.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Bosutinib in Combination With Pemetrexed in Patients With Selected Metastatic Solid Tumors Carcinoma, Non-Small-Cell Lung, Mesothelioma, Bladder Cancer | Phase 1 | 2019-12-10 |